2,5-dimethoxy-4-methylamphetamine (DOM,STP) 的起源是什么
1Shulgin Archive, Trouts Notes, Boonville, California, USA.
Drug testing and analysis
|February 29, 2024
概括
亚历山大·舒尔金 (Alexander Shulgin) 是一个俄罗斯人.
科学领域:
- 精神活性物质研究 精神活性物质研究
- 神经科学是一个神经科学.
- 心理药理学的历史
背景情况:
- 1967年出现的2,5-二甲基-4-甲基胺 (DOM,STP) 往往是不准确的报道.
- 亚历山大·舒尔金在DOM供应方面的作用尚未得到广泛理解.
- DOM从实验性治疗潜力转变为一种街头毒品,具有负面的公众看法.
研究的目的:
- 提供对DOM (STP) 的出现和分布的准确历史记录.
- 为了澄清亚历山大·舒尔金的参与和动机.
- 探索DOM的科学贡献,尽管它的臭名昭著.
主要方法:
- 发表和未发表的历史来源的审查.
- 分析舒尔金的潜在风险和动机.
- 审查DOM的科学实用性和对危机应对的影响.
主要成果:
- 舒尔金在提供DOM材料方面的作用是详细的,解决了职业风险.
- 突出了DOM在心理治疗应用和分子神经科学中的潜力.
- 关于DOM和 хлорпромазин相互作用的错误信息改善了药物危机反应.
结论:
- 准确的历史记录对于理解精神活性物质的发展至关重要.
- 尽管DOM有着街头毒品的声誉,但它提供了对受体特异性的见解.
- 从DOM的出现中吸取的经验教训影响了非药物危机干预.
相关概念视频
Carboxylic Acids to Methylesters: Alkylation using Diazomethane
2.2K
Carboxylic acids react with diazomethane in an ether solvent via alkylation at the carboxylate oxygen atom to give methyl esters of the corresponding acid with excellent yields.
2.2K
Phase II Reactions: Methylation Reactions
187
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
187
Preparation of 1° Amines: Gabriel Synthesis
3.5K
Direct alkylation is not a suitable method for synthesizing amines because it produces polyalkylated products. Gabriel synthesis is the most preferred method to exclusively make primary amines. The method uses phthalimide, which contains a protected form of nitrogen that participates in alkylation only once to predominantly give primary amines.
Strong bases like NaOH or KOH deprotonate the phthalimide to form the corresponding anion, which acts as a nucleophile. Further, the anion attacks an...
Strong bases like NaOH or KOH deprotonate the phthalimide to form the corresponding anion, which acts as a nucleophile. Further, the anion attacks an...
3.5K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.0K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.0K
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Adrenergic Agonists: Indirect-Acting Agents
1.6K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.6K


